Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/ASO.2004.06.007
Annals of Surgical Oncology 11:674-681 (2004)
© 2004 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellner, S. J.
Right arrow Articles by Wallace, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellner, S. J.
Right arrow Articles by Wallace, A. M.

ORIGINAL ARTICLES

Sentinel Lymph Node Mapping of the Colon and Stomach Using Lymphoseek in a Pig Model

Scott J. Ellner, DO, MPH, Jeanette Méndez, MD, David R. Vera, PhD, Carl K. Hoh, MD{dagger}, William L. Ashburn, MD and Anne M. Wallace, MD, FACS

From the Departments of Surgery (SJE, AMW), Radiology (JM, DRV, CKH, WLA), and Medicine (JM) and the University of California, San Diego Comprehensive Cancer Center (SJE, DRV, CKH, AMW), University of California, San Diego, La Jolla, California.

Correspondence: Address correspondence and reprint requests to: Anne M. Wallace, MD, FACS, Theodore Gildred Cancer Facility, 200 West Arbor Drive, San Diego, CA 92103-8421; Fax: 619-543-6644; E-mail: amwallace{at}ucsd.edu

Background: Lymphoseek is a radiopharmaceutical designed for sentinel lymph node (SLN) mapping. The purpose of this study was to compare Lymphoseek colon and gastric pharmacokinetics with filtered [99mTc]sulfur colloid (fTcSC).

Methods: Eight anesthetized pigs received an endoscopic injection of Lymphoseek or fTcSC in the stomach and colon. Scintigraphy was obtained of both administration sites at 15-minute intervals up to 3 hours after injection, after which all SLNs were identified by a handheld gamma probe through a laparotomy incision. Isosulfan blue was administered at the injection site 5 minutes before SLN mapping. The percentage of injected dose (%ID) was measured for all harvested nodes, and the clearance half-life (Tc) was calculated for all injection sites.

Results: The mean Lymphoseek clearance for colon (Tc, 2.56 ± 1.04 hours) and gastric (Tc, 3.83 ± 1.18 hours) injection sites was statistically faster (P = .030) compared with fTcSC (colon Tc, 14.98 ± 3.41 hours; stomach Tc, 14.52 ± 4.08 hours). After 3 hours, Lymphoseek exhibited a mean SLN %ID of 1.32% ± 1.71% in the colon and 2.04% ± 2.12% in the stomach; this was not statistically different from fTcSC (colon, .63% ± .39%; stomach, 2.35% ± 2.90%). SLN uptake of Lymphoseek was significantly different from second-echelon node %ID for the colon (P = .011) and gastric (P = .029) injection sites. All SLNs exceeded 10 times background, and there was no discordance between isosulfan blue and Lymphoseek or fTcSC.

Conclusions: Three hours after colon stomach administration, Lymphoseek demonstrated rapid injection site clearance, detectable SLN uptake, and low second-echelon node uptake.

Key Words: Sentinel lymph node • Colon cancer • Gastric cancer • Radiopharmaceutical • [99mTc]DTPA-mannosyl-dextran • Lymphoseek




This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
A. M. Wallace, C. K. Hoh, S. J. Ellner, D. D. Darrah, G. Schulteis, and D. R. Vera
Lymphoseek: A Molecular Imaging Agent for Melanoma Sentinel Lymph Node Mapping
Ann. Surg. Oncol., February 1, 2007; 14(2): 913 - 921.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society of Surgical Oncology.